Mortality in sickle cell patients on hydroxyurea therapy.

被引：0
|
作者：
Bakanay, SM [1 ]
Dainer, E [1 ]
Clair, B [1 ]
Daitch, L [1 ]
Wells, L [1 ]
Holley, L [1 ]
Kutlar, A [1 ]
机构：
[1] Med Coll Georgia, Sickle Cell Ctr, Augusta, GA 30912 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2807
引用
收藏
页码：760A / 761A
页数：2
相关论文
共 50 条
  • [31] Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy
    Iyamu, EW
    Cecil, R
    Parkin, L
    Woods, G
    Ohene-Frempong, K
    Asakura, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (03) : 389 - 394
  • [32] Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy
    Saleh, AW
    Duits, AJ
    Gerbers, A
    de Vries, C
    Hillen, HFP
    ACTA HAEMATOLOGICA, 1998, 100 (01) : 26 - 31
  • [33] ADHERENCE TO HYDROXYUREA THERAPY IN SICKLE CELL ANEMIA PATIENTS DURING THE COVID 19 PANDEMIC
    Bresler, Michele
    Kasangottu, Anoosha
    Raybagkar, Deepti
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S32 - S32
  • [34] Perception to Hydroxyurea Therapy in Patients with Sickle Cell Disease: Report from 3 Centers
    Korubo, Kaladada I.
    Onodingene, Nkemsinachi Maryanne
    Okoye, Helen Chioma
    Omunakwe, Hannah E.
    ANNALS OF AFRICAN MEDICINE, 2021, 20 (02) : 127 - 131
  • [35] The effects of hydroxyurea treatment in Bahraini patients with sickle cell anemia and sickle cell thalassemias
    Shome, D. K.
    Al Ajmi, A.
    Radhi, A.
    Jassim, E.
    Salih, F. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 534 - 534
  • [36] EVALUATION OF HYDROXYUREA AND ERYTHROPOIETIN THERAPY IN SICKLE-CELL DISEASE
    GOLDBERG, MA
    BRUGNARA, C
    DOVER, GJ
    SCHAPIRA, L
    CHARACHE, S
    CLINICAL RESEARCH, 1990, 38 (02): : A300 - A300
  • [37] Effect of Hydroxyurea on Microalbuminuria in Patients with Sickle Cell Disease
    Sah, Jeetendra
    Lalan, Shwetal
    Peichev, Mario
    Viswanathan, Kusum
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S20 - S20
  • [38] Malignancies in sickle cell disease patients treated with hydroxyurea
    Ferster, A
    Sariban, E
    Meuleman, N
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (02) : 368 - 369
  • [39] Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
    Di Grazia, Daniela
    Mirabella, Cristina
    Chiara, Francesco
    Caudana, Maura
    Agar, Francesco Maximillian Anthony Shelton
    Zanatta, Marina
    Allegra, Sarah
    Bertello, Jenni
    Voi, Vincenzo
    Ferrero, Giovanni Battista
    Abbadessa, Giuliana
    De Francia, Silvia
    PHARMACEUTICALS, 2024, 17 (10)
  • [40] Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
    Moreira de Oliveira, Emanuel Almeida
    Boy, Kenia de Assis
    Pinho Santos, Ana Paula
    Machado, Carla da Silva
    Velloso-Rodrigues, Cibele
    Almeida Silva Gerheim, Pamela Souza
    Mendonca, Leonardo Meneghin
    EINSTEIN-SAO PAULO, 2019, 17 (04): : eAO4742
12345